H2CBD, a synthetic version of the cannabis compound CBD, has been found to be effective in decreasing the number and severity of seizures in rats.
New findings reveal exercise increases levels of endocannabinoids in the body. The findings may explain some of the beneficial effects of exercise on the brain and body.
Eating a high-fat diet can help with the absorption of oral CBD for those with epilepsy. Previous studies have linked CBD to helping manage seizures associated with epilepsy.
During memory tasks, people with psychosis have different patterns of activity in the prefrontal and mediotemporal brain areas compared to those without the disorder. When exposed to cannabidiol (CBD), the activity of the brain areas became more like those seen in the controls for people with psychosis. Patients reported a decrease in symptoms of psychosis following one dose of CBD. Researchers stress that no definitive conclusions could be made about the effectiveness of CBD use over a sustained period.
Children with drug-resistant epilepsy may find relief with the help of medical cannabis oil that contains both CBD and lose dose THC. The oil, which contains 95% CBD and 5% THC, can reduce or prevent epileptic seizures in those with epileptic encephalopathy.
Study demonstrates the short-term effects of marijuana on human motivation.
A new study aims to determine if the cannabis compound CBD can help to alleviate adverse symptoms associated with ASD.
Staphylococcal enterotoxin, a bacterial toxin implicated in some ARDS cases, can be prevented by treatment with the cannabis compound THC. Findings also suggest a potential role for using cannabinoids to treat ARDS caused by COVID-19.
Pure CBD products will not cause a positive drug test, but low-THC/high-CBD products may trigger a positive drug test for some users.
Cannabidiol may be able to bypass the blood-brain barrier to effectively deliver medications directly to the brain.
A new study in Zebrafish reveals exposure to compounds found in cannabis during the early stages of development was linked to a significant drop in neural activity later in life.
A new study reveals cannabinoid medications may not reduce pain itself, but instead make pain feel less unpleasant and more tolerable.
